Scanogen Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$6.63M
- Investors
-
5
Scanogen General Information
Description
Operator of a biotechnology and medical device company intended to directly detect DNA. The company develops a technology for direct detection of DNA and it also offers Single Molecule Scanning, a technology for ultra-sensitive detection of biomolecules, enabling users to detect nucleic acid molecules.
Contact Information
Website
www.scanogen.com
Formerly Known As
Twistnostics LLC
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Primary Office
- 3102 Lord Baltimore Drive
- Suite 214
- Baltimore, MD 21244
- United States
Scanogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 01-Jan-2017 | $6.63M | Completed | Startup | ||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 19-Sep-2013 | $153K | Completed | Startup |
Scanogen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology and medical device company intended to directly detect DNA. The company develops a technolog
Other Devices and Supplies
Baltimore, MD
10
As of 2019
0000000000
00 000
ris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000000000 000000000
Lexington, MA
000
As of 0000
00000
00000000000
00000
Add Comparison
Scanogen Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 00 0000000000 | Formerly VC-backed | Lexington, MA | 000 | 00000 | 00000000000 | 00000 |
Scanogen Patents
Scanogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190361016-A1 | Detection units and methods for detecting a target analyte | Pending | 25-May-2018 | 000000000000 | |
| US-20190040344-A1 | Device and method for sample analysis | Abandoned | 27-Jul-2017 | 000000000 | |
| US-10768406-B2 | Imaging system | Active | 20-Jun-2016 | 0000000000 | 0 |
| US-20170363851-A1 | Imaging system | Granted | 20-Jun-2016 | 0000000000 | 0 |
| US-20200400932-A1 | Imaging system | Pending | 20-Jun-2016 | G02B21/361 |
Scanogen Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Alfredo Celedon Ph.D | Founder & Chief Executive Officer |
Scanogen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Scanogen Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| National Cancer Institute | Government | 000 0000 | 000000 0 | ||
| The National Human Genome Research Institute | Government | 000 0000 | 000000 0 | ||
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
| Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |